Change over period: —
NSE · PROTEAN
PROTEAN
-22.7% from the 52-week high · +50.5% above the low
Protean EGov Technologies Ltd offers digital solutions for government and corporate sectors, including financial services and compliance management. The company integrates technology platforms to simplify processes, enhance transparency, and improve service delivery.
The short version. PROTEAN reported revenue of ₹271 crore for Sep 2026, up 8.4% from a year earlier. Net profit was ₹16 crore (down 33.3% year on year). Return on equity was 9.3% in Mar 2026.
1 · The price
How has the stock traded?
PROTEAN trades 22.7% below its 52-week high and 50.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹271 cr.
Sep 2026 net profit of ₹16 cr.
3.4 pts lower than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 271 | 251 | 308 | 229 | 250 | 211 | 222 | 202 |
| Net profit | 16 | 6 | 30 | 22 | 24 | 24 | 20 | 23 |
| Net margin % | 6.1 | 2.3 | 9.9 | 9.8 | 9.5 | 11.3 | 9.2 | 11.3 |
| EPS (₹) | 4.02 | 1.44 | 7.48 | 5.54 | 5.88 | 5.88 | 5.03 | 5.66 |
Annual
| FY2026 | FY2025 | FY2024 | |
|---|---|---|---|
| Revenue | 998 | 841 | 882 |
| Net profit | 101 | 92 | 97 |
| Net margin % | 10.1 | 11.0 | 11.0 |
| EPS (₹) | 24.77 | 22.8 | 24.05 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 9.3% in Mar 2026; debt to equity is 0.00.
Profitability · 3 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Return on equity % | 9.3 | 9.3 | 10.5 |
| Return on capital % | 11.7 | 11.2 | 13.5 |
| EBITDA margin % | 17.2 | 16.4 | 16.5 |
| Net margin % | 9.4 | 10.2 | 10.2 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Down 5.21 pts over 8 quarters.
Down 8.6 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 9.91 | 10.91 | 8.79 | 7.77 | 7.54 | 8.61 | 6.01 | 4.7 | -5.21 |
| DII | 30.09 | 27.79 | 24.74 | 21.68 | 21.46 | 21.25 | 21.15 | 21.49 | -8.6 |
| Public | 60.0 | 61.3 | 66.47 | 70.55 | 71.01 | 70.14 | 72.84 | 73.81 | +13.81 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
2 the month before.
- Mirae Asset BSE Information Technology Index Fund0.18% of NAV
- NIPPON INDIA SMALL CAP FUND0.12% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for PROTEAN are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other IT - Services stocks
Quick answers
Common questions about PROTEAN
What is the PROTEAN share price?
PROTEAN (PROTEAN) last closed at ₹712.10, up 6.0% on the day. Its 52-week range is ₹446.40 to ₹868.90.
What is the market cap of PROTEAN?
PROTEAN has a market capitalisation of about ₹2,436 crore.
How are PROTEAN's latest results?
PROTEAN reported revenue of ₹271 crore for Sep 2026, up 8.4% from a year earlier. Net profit was ₹16 crore (down 33.3% year on year). Return on equity was 9.3% in Mar 2026.
Who owns PROTEAN?
As of Sep 2026, shareholding was: FII 4.7%, DII 21.49%, Public 73.81%.
How many mutual funds hold PROTEAN?
2 mutual fund schemes held PROTEAN in October 2026. That compares with 2 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 29 Aug 2025 · Final Dividend - Rs. 10
- 06 Sep 2024 · Final Dividend - Rs. 10
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.